A Novel ‘Piggyback’ Packaging System for Herpes Simplex Virus Amplicon Vectors
- 20 October 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (16) , 2003-2013
- https://doi.org/10.1089/hum.1996.7.16-2003
Abstract
Recombinant and amplicon vectors derived from herpes simplex virus type 1 (HSV-1) have proven to be an efficient means of gene delivery to cells in culture and in vivo. In this study, a system was developed to make propagation of the amplicon vector and helper virus mutually dependent on each other, in a ‘piggyback’ fashion. This combined system supports maintenance and enrichment of the amplicon vector when propagating stocks, while allowing the helper virus to serve as a recombinant vector in its own right. Amplicons bearing a gene essential for HSV-1 replication, IE3, as well as the Escherichia coli lacZ marker gene, were propagated using a mutant virus (d120) deleted in the same essential gene. Vector stocks could be propagated in Vero cells and other cultured cells not transfected with the IE3 gene with markedly delayed cytopathic effects, as compared to wild-type virus. Relatively high titers of amplicon vectors (6 × 107 infectious units/ml) were achieved with this piggyback system in Vero cells, with an apparent ratio of amplicon vector: helper virus of up of 5:1 under some conditions; however, recombinant wild-type virus was also generated. Injection of these stocks into experimental gliomas in rodent brain revealed gene delivery to tumor cells mediated by both amplicon vectors (lacZ) and helper virus (HSV-thymidine kinase), with no apparent neuropathology of normal brain. This basic piggyback vector model is amenable to modifications to promote conditional propagation of vectors in vivo and to allow incorporation of multiple transgene elements into both the amplicon and recombinant helper virus vectors. Herpes vectors offer a potential means to achieve therapeutic gene delivery into brain tumors. One current limitation to these vectors includes toxicity of the replicating viruses for the brain. Our idea is directed toward decreasing the neurotoxicity by using recombinant virus and amplicon type vectors in a ‘piggyback’ fashion. We describe a piggyback system in which propagation of an amplicon vector, encoding the IE3 gene essential for herpes simplex virus (HSV) replication, and a mutant helper virus, deleted in the same replication-essential gene, is mutually dependent. This combined system is able to replicate in vivo in rat 9L glioblastoma tumors in a rat brain. The new system also expands the number of transgenes that can be delivered simultaneously by using amplicon vectors, in combination with recombinant virus vectors, which provide helper virus function and at the same time serve as a vehicle for other transgenes.Keywords
This publication has 40 references indexed in Scilit:
- Gene Therapy for Brain TumorsBrain Pathology, 1995
- Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteinsMolecular Brain Research, 1995
- Herpes simplex virus 1 (HSV-1) helper co-infection affects the distribution of an amplicon encoded protein in gliaNeuroReport, 1994
- Gene delivery to neurons: Is herpes simplex virus the right tool for the job?BioEssays, 1993
- Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vectorMolecular and Cellular Neuroscience, 1991
- The herpes simplex virus amplicon IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomesVirology, 1985
- JC Virus Enhancer-Promoter Active in Human Brain CellsScience, 1984
- The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vectorCell, 1982
- The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in miceEpidemiology and Infection, 1978
- Induction of Both Thymidine and Deoxycytidine Kinase Activity by Herpes VirusesJournal of General Virology, 1974